According to Kilroy Realty's latest financial reports the company's current revenue (TTM) is $1.11 B. In 2022 the company made a revenue of $1.09 B an increase over the years 2021 revenue that were of $0.95 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.12 B | 2.98% |
2022 | $1.09 B | 14.86% |
2021 | $0.95 B | 6.3% |
2020 | $0.89 B | 7.28% |
2019 | $0.83 B | 12.06% |
2018 | $0.74 B | 3.94% |
2017 | $0.71 B | 11.89% |
2016 | $0.64 B | 10.55% |
2015 | $0.58 B | 11.41% |
2014 | $0.52 B | 12.7% |
2013 | $0.46 B | 15.85% |
2012 | $0.39 B | 14.42% |
2011 | $0.34 B | 15.86% |
2010 | $0.30 B | 7.88% |
2009 | $0.27 B | -3.53% |
2008 | $0.28 B | 15.42% |
2007 | $0.25 B | 0.35% |
2006 | $0.25 B | 4.24% |
2005 | $0.23 B | 9.6% |
2004 | $0.21 B | -2.45% |
2003 | $0.22 B | 11.01% |
2002 | $0.20 B | -3.58% |
2001 | $0.20 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Microsoft MSFT | $236.58 B | 21,109.30% | ๐บ๐ธ USA |
Intuit INTU | $15.81 B | 1,317.60% | ๐บ๐ธ USA |
Splunk SPLK | $3.98 B | 256.85% | ๐บ๐ธ USA |
Neurocrine Biosciences
NBIX | $1.98 B | 77.68% | ๐บ๐ธ USA |